ACTH following overnight dexamethasone suppression can be used in the verification of autonomous cortisol secretion in patients with adrenal incidentalomas
Clinical Endocrinology Nov 02, 2020
Puvaneswaralingam S, Kjellbom A, Lindgren O, et al. - Given the significance of an accurate diagnosis of autonomous cortisol secretion (ACS) along with low specificity of cortisol ≥50 nmol/l after overnight dexamethasone suppression (cortisolONDST), researchers examined the value of ACTH following overnight dexamethasone suppression (ACTHONDST) and cortisol following a 2‐day dexamethasone suppression test (cortisol2‐DAYDST) as markers of HPA‐axis suppression during ONDST. They conducted a cross‐sectional study examining patients with adrenal incidentalomas and basal ACTH ≥ 2.0 pmol/l. Outcomes suggest the possible utility of ACTHONDST and ACTH‐ratio as markers of HPA‐axis suppression in the investigation of adrenal incidentalomas. ACS should be suspected in cases with CortisolONDST ≥ 50 nmol/l with ACTHONDST < 0.6 pmol/l or ACTH‐ratio < 18%.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries